Montgomery-Åsberg Depression Rating Scale factors in treatment-resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine.
Stephane BorentainJagadish GogateDavid WilliamsonThomas CarmodyMadhukar H TrivediCarol JamiesonPatricia CabreraVanina PopovaEwa WajsAllitia DiBernardoElla J DalyPublished in: International journal of methods in psychiatric research (2022)
A three-factor structure for MADRS appears to generalize to TRD. All three factors improved over 4 weeks of treatment with esketamine nasal spray.